Evidence map›Paper›PMID 34980980›Full record

ArticleInnovations in clinical neuroscience

Brain Health Executives: A Transdisciplinary Workforce Innovation-A Commentary.

Harris A Eyre, Michael Berk, Erin Smith, Jeffrey Cummings, Mark Heinemeyer

Open access · greenAbstract readEditorial
PubMed Full text at PMC
In one paragraph

Article in Innovations in clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 3 countries.

Harris A EyreDr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and School of Medicine at Deakin University in Geelong, Australia; the Global Brain Health Institute (GBHI) at the University of California, San Francisco; the Department of Psychiatry at Baylor College of Medicine in Houston, Texas; Trinity University in Dublin, Ireland, and Neuroscience-inspired Policy Initiative at the Organisation for Economic Co-Operation and Development (OECD) in Paris, France.
Michael BerkDr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and School of Medicine at Deakin University in Geelong, Australia; the Global Brain Health Institute (GBHI) at the University of California, San Francisco; the Department of Psychiatry at Baylor College of Medicine in Houston, Texas; Trinity University in Dublin, Ireland, and Neuroscience-inspired Policy Initiative at the Organisation for Economic Co-Operation and Development (OECD) in Paris, France.
Erin SmithDr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and School of Medicine at Deakin University in Geelong, Australia; the Global Brain Health Institute (GBHI) at the University of California, San Francisco; the Department of Psychiatry at Baylor College of Medicine in Houston, Texas; Trinity University in Dublin, Ireland, and Neuroscience-inspired Policy Initiative at the Organisation for Economic Co-Operation and Development (OECD) in Paris, France.
Jeffrey CummingsDr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and School of Medicine at Deakin University in Geelong, Australia; the Global Brain Health Institute (GBHI) at the University of California, San Francisco; the Department of Psychiatry at Baylor College of Medicine in Houston, Texas; Trinity University in Dublin, Ireland, and Neuroscience-inspired Policy Initiative at the Organisation for Economic Co-Operation and Development (OECD) in Paris, France.
Mark HeinemeyerDr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and School of Medicine at Deakin University in Geelong, Australia; the Global Brain Health Institute (GBHI) at the University of California, San Francisco; the Department of Psychiatry at Baylor College of Medicine in Houston, Texas; Trinity University in Dublin, Ireland, and Neuroscience-inspired Policy Initiative at the Organisation for Economic Co-Operation and Development (OECD) in Paris, France.
University of Nevada, Las Vegas · US

Funding

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI Robert J. Fox, Jefferson Kinney · 2015 to 2026
$22.8M
NVEDARC Clinical CoreP20AG068053 · NIA · CLEVELAND CLINIC FOUNDATION · PI FOX, ROBERT J. · 2020 to 2022
$3.3M
NIA NIH HHS P20 AG068053NIGMS NIH HHS P20 GM109025
6 · The paper itself

Abstract

Given the rapidly evolving landscape of technologies, social, health, and consumer trends, the development of effective Brain Health Executives is a key workforce innovation. Convergence Brain Health involves the integration of scientists, clinicians, bioinformaticists, global health experts, social scientists, engineers, technology entrepreneurs, medical educators, caregivers, and consumers. Synergy between government, academia, and industry is also vital. The discipline of Brain Health Executives provides a novel workforce approach to ensure we have individuals who can meet the demands of Convergence Brain Health. The optimal persona of an effective Brain Health Executive will include these core elements: a certain mindset, sufficient clinical experience to understand clinical realities and research experience to understand methodology and process, business experience in critical functional areas, informed perspectives on platform design and deep technologies in brain health, fluency with novel funding mechanisms, a progressive interest in the emerging fields across brain health, the ability to see where point solutions fit within broader product symphonies and the brain health landscape, and the facility to apply proven business and commercialization practices from not only other fields of medicine, but other industries. Promising initiatives for training and workforce development, such as Stanford University Brainstorm Mental Health Innovation Lab and the Global Brain Health Institute, may serve as predicates for the novel Brain Health Executive model. Small, agile, highly collaborative, and emotionally intelligent teams may help form the ideal Brain Health Executives in the short-term. This commentary explores the discipline of convergence of science and its role in addressing the current global brain health crisis.

Indexed as

Brain healthentrepreneurshipinnovationleadershipmanagementmental disordersneurosciencepsychiatrytechnology

Identifiers

PMID34980980
PMCPMC8667705
OpenAlexW4206895922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.